These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 22252444)

  • 1. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.
    Huang CJ; Lin H; Yang X
    J Ind Microbiol Biotechnol; 2012 Mar; 39(3):383-99. PubMed ID: 22252444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
    Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
    J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications.
    Gupta SK; Shukla P
    Crit Rev Biotechnol; 2016 Dec; 36(6):1089-1098. PubMed ID: 26384140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering cell physiology to enhance recombinant protein production in Escherichia coli.
    Chou CP
    Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of therapeutic proteins production in Escherichia coli.
    Kamionka M
    Curr Pharm Biotechnol; 2011 Feb; 12(2):268-74. PubMed ID: 21050165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced genetic strategies for recombinant protein expression in Escherichia coli.
    Sørensen HP; Mortensen KK
    J Biotechnol; 2005 Jan; 115(2):113-28. PubMed ID: 15607230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli as a glycoprotein production host: recent developments and challenges.
    Jaffé SR; Strutton B; Levarski Z; Pandhal J; Wright PC
    Curr Opin Biotechnol; 2014 Dec; 30():205-10. PubMed ID: 25156401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli.
    Fisher AC; Haitjema CH; Guarino C; Çelik E; Endicott CE; Reading CA; Merritt JH; Ptak AC; Zhang S; DeLisa MP
    Appl Environ Microbiol; 2011 Feb; 77(3):871-81. PubMed ID: 21131519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant protein folding and misfolding in Escherichia coli.
    Baneyx F; Mujacic M
    Nat Biotechnol; 2004 Nov; 22(11):1399-408. PubMed ID: 15529165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the productivity of recombinant protein in Escherichia coli under thermal stress by coexpressing GroELS chaperone system.
    Kim SY; Ayyadurai N; Heo MA; Park S; Jeong YJ; Lee SG
    J Microbiol Biotechnol; 2009 Jan; 19(1):72-7. PubMed ID: 19190411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins.
    Groff D; Armstrong S; Rivers PJ; Zhang J; Yang J; Green E; Rozzelle J; Liang S; Kittle JD; Steiner AR; Baliga R; Thanos CD; Hallam TJ; Sato AK; Yam AY
    MAbs; 2014; 6(3):671-8. PubMed ID: 24517929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Escherichia coli production of therapeutic proteins.
    Swartz JR
    Curr Opin Biotechnol; 2001 Apr; 12(2):195-201. PubMed ID: 11287237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.
    Sharma A; Chaudhuri TK
    Microb Cell Fact; 2017 Oct; 16(1):173. PubMed ID: 28982367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of antibodies in SHuffle Escherichia coli strains.
    Eaglesham JB; Garcia A; Berkmen M
    Methods Enzymol; 2021; 659():105-144. PubMed ID: 34752282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles and applications of small heat shock proteins in the production of recombinant proteins in Escherichia coli.
    Han MJ; Park SJ; Park TJ; Lee SY
    Biotechnol Bioeng; 2004 Nov; 88(4):426-36. PubMed ID: 15382106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
    Hatfield GW; Roth DA
    Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in biopharmaceuticals production in Escherichia coli.
    McElwain L; Phair K; Kealey C; Brady D
    Biotechnol Lett; 2022 Aug; 44(8):917-931. PubMed ID: 35796852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of fermentation of recombinant human Endostatin (rh-Endostatin) expression in Escherichia coli].
    Chang GD; Li ZL; Qin JY; Ma CQ; Luo YZ; Xu P
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):662-6. PubMed ID: 16176112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.